Home/Filings/4/0001193125-25-286236
4//SEC Filing

Young Teresa L. 4

Accession 0001193125-25-286236

CIK 0001609809other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:30 PM ET

Size

16.0 KB

Accession

0001193125-25-286236

Insider Transaction Report

Form 4
Period: 2025-11-15
Young Teresa L.
See Remarks
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-1598878 total
    Common Stock (98 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-15+1329,345 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-153,9980 total
    Common Stock (3,998 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-11-15132664 total
    Common Stock (132 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-15+989,443 total
  • Sale

    Common Stock

    2025-11-15$17.30/sh1,042$18,0278,401 total
  • Exercise/Conversion

    Common Stock

    2025-11-15+3,9989,213 total
Footnotes (5)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 5, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.
  • [F3]The RSUs vested in a single installment on November 15, 2025. The RSUs have no expiration date.
  • [F4]The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.
  • [F5]The restricted stock units vested and settled as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.

Documents

1 file

Issuer

Seres Therapeutics, Inc.

CIK 0001609809

Entity typeother

Related Parties

1
  • filerCIK 0001814656

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:30 PM ET
Size
16.0 KB